SCHEMBL10019239

SCHEMBL10019239

CC(=O)N(CCCCI)c1cccc(C#N)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.41
KCNA5 P22460 1/20 0.41
GSK3B P49841 2/20 0.38
KDM4E B2RXH2 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
MAPK1 P28482 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
AOX1 Q06278 1/20 0.37
PDE3A Q14432 1/20 0.37
ALDH1A1 P00352 3/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
GPX4 P36969 1/20 0.36
PAX8 Q06710 1/20 0.36
FFAR1 O14842 1/20 0.36
MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10019242 0.88 KCNN4 (0.41) KCNN4KCNA5GSK3BKDM4EGABRA1
SCHEMBL14034672 0.81 ALDH1A1 (0.54) KDM4EALDH1A1RAB9ANPC1TP53
SCHEMBL5036230 0.80 KDM4E (0.51) KCNN4KCNA5GSK3BKDM4EGABRA1
SCHEMBL5885580 0.77 KCNN4 (0.40) KCNN4KCNA5GSK3BKDM4EGABRA1
SCHEMBL10019243 0.75 KCNN4 (0.37) KCNN4KCNA5KDM4EGABRA1GABRG2
SCHEMBL14229160 0.74 TP53 (0.52) KCNN4KCNA5ALDH1A1RAB9ANPC1
SCHEMBL5886035 0.73 KDM4E (0.39) KCNN4KCNA5GSK3BKDM4EGABRA1
SCHEMBL17265581 0.72 MAPK14 (0.45) KCNN4KCNA5GSK3BALDH1A1FFAR1
SCHEMBL29603007 0.72 KCNN4 (0.43) KCNN4KCNA5GSK3BMAPK1ALDH1A1
SCHEMBL28785615 0.72 KCNN4 (0.43) KCNN4KCNA5GSK3BMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101619-B2 Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition SOLVAY PHARMACEUTICALS B.V. (NL) 2012-01-24 US disclosed
US-8101619-B2 Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition SOLVAY PHARMACEUTICALS B.V. (NL) 2012-01-24 US disclosed
EP-1827427-B1 ARYLOXYETHYLAMINE DERIVATIVES WITH A COMBINATION OF PARTIAL DOPAMINE-D2 RECEPTOR AGONISM AND SEROTONIN REUPTAKE INHIBITION SOLVAY PHARM BV (NL) 2008-07-23 EP disclosed